Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-11

Clinical Trial Update: Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating toripalimab with chemotherapy as neoadjuvant treatment for gastric cancer is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chemotherapy (chemotherapy)
  • Toripalimab (Toripalimab)

Snippet

Sponsor: Aiping Zhou | Conditions: Gastric Cancer Stage II, Gastric Cancer Stage III | Phase 2 | Status: UNKNOWN